GO-2-ME and rGO 2-ME hybrids

Chemotherapy is one of the basic forms of oncological treatment, but its effectiveness is limited by systemic toxicity, suboptimal effectiveness and chemoresistance of cancer cells. For this reason, new and more selective therapeutic methods are constantly being sought, including: based on nanoparticles as drug carriers, with unique biophysicochemical properties, especially in the area of binding xenobiotics and physiological metabolites, including absorption, penetration of biological membranes, volume of distribution, and, consequently, bioavailability and potential selectivity of the chemotherapeutic agent.